Power of Gut Microbes: Effect of Early Detection of Gestational Diabetes

Researchers have shown that gestational diabetes can be identified as early as the first trimester of pregnancy, which is typically months before it is typically diagnosed.

Gestational diabetes can be diagnosed in the first trimester of pregnancy, much earlier than the standard diagnosis period, with several months of difference as per a new Bar-Ilan University study, published in the journal Gut.

Gestational diabetes mellitus (GDM) is a condition in which women without diabetes develop glucose intolerance during pregnancy. GDM, which plagues approximately 10% of pregnant women worldwide, is currently diagnosed in the second trimester of pregnancy.

Gestational Diabetes About
The condition is not caused by a lack of insulin, but by the action of hormones produced during pregnancy that blocks the action of insulin.

‘Gestational diabetes can be detected in the first trimester of pregnancy, months earlier than usual, according to a recent study.’

The new study, led by Prof. Omry Koren, of the Azrieli Faculty of Medicine of Bar-Ilan University, and a team of Israeli and international researchers, is one of the first to show reliable prediction of GDM months before it is typically diagnosed.

There are marked differences in the first-trimester gut microbiota (the bacterial population found in the guts of humans and animals) of women who do and do not later develop gestational diabetes.

These differences are associated with inflammatory markers, with women who develop gestational diabetes exhibiting higher inflammation and lower levels of beneficial metabolites.

Microbial Link between Gut Health and Gestational Diabetes Mellitus (GDM)
Gut health reflected by gut microbiota helps manage diabetes mellitus in pregnant women known as Gestational Diabetes Mellitus (GDM). Gut microbiota imbalance during pregnancy induces glucose intolerance and, thereby, gestational diabetes.

Healthy Pregnancy Starts with Gut Health In the study fecal and serum samples were collected from pregnant women during their first trimester. The microbiota, metabolite, inflammation, and hormone profiles were characterized. Diet, smoking, and other lifestyle habits were recorded, and clinical/medical data was compiled from digital health records.

Using the results of these characterizations, combined with other collected data, Prof. Yoram Louzoun, from the Department of Mathematics and Gonda (Goldschmied) Multidisciplinary Brain Research Center, built a machine learning model that can accurately predict which women would and would not go on to develop gestational diabetes.

Diabetes - Oral Hypoglycemic Agents and Glycemic Control
Glycemic control in type 2 diabetes is achieved with oral diabetic medications. Combination drugs and insulin therapy is sometimes required.

The researchers then demonstrated in animal models that transferring the first-trimester feces of women that went on to develop gestational diabetes results in transfer of the diabetes phenotype to germ-free mice, suggesting that the gut microbiome has a role in mediating disease development.

The study findings are not population specific. The microbiome model, for example, could predict GDM in Chinese women, and the mice results were replicated in Finnish and American cohorts.

"Recognition of women at risk of gestational diabetes at an early stage of pregnancy may allow specific recommendations for the prevention of the disease -- currently by lifestyle modification and in the future perhaps by specific pre, pro, and postbiotic supplementation," says Prof. Koren.

If gestational diabetes can be prevented, there would be a major reduction in adverse outcomes of gestational diabetes, for the mother and offspring, in both the short and long term, benefiting families worldwide.

Source-Eurekalert